Building a Renewed ImaGe After Head & Neck Cancer Treatment
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/3/2019 |
| Start Date: | February 8, 2018 |
| End Date: | August 25, 2019 |
| Contact: | Evan Graboyes, M.D. |
| Email: | graboyes@musc.edu |
| Phone: | (843) 792-0719 |
This study will evaluate whether a time-limited cognitive behavioral therapy (CBT)
intervention in the post-treatment time period can address body image disturbance (BID) in
patients with surgically-treated head and neck cancer (HNC), thereby improving BID and
quality of life (QOL).
intervention in the post-treatment time period can address body image disturbance (BID) in
patients with surgically-treated head and neck cancer (HNC), thereby improving BID and
quality of life (QOL).
The investigators will complete a single-arm, phase II pilot study of time-limited CBT on BID
in patients with surgically-treated HNC. Reliable, validated patient-reported outcome (PRO)
measures of BID will be collected before, 1 month and 3 months after the CBT intervention to
provide preliminary data on the effectiveness of CBT for BID in patients with
surgically-treated HNC, addressing this critical knowledge gap. It is expected that
time-limited CBT implemented in the post-treatment period will decrease BID and improve QOL
in affected patients.
in patients with surgically-treated HNC. Reliable, validated patient-reported outcome (PRO)
measures of BID will be collected before, 1 month and 3 months after the CBT intervention to
provide preliminary data on the effectiveness of CBT for BID in patients with
surgically-treated HNC, addressing this critical knowledge gap. It is expected that
time-limited CBT implemented in the post-treatment period will decrease BID and improve QOL
in affected patients.
Inclusion Criteria:
- Pathologic diagnosis of squamous cell carcinoma of the upper aerodigestive tract (oral
cavity, oropharynx, hypopharynx, larynx) or cutaneous malignancy of the head and neck
(e.g. squamous cell, basal cell, melanoma, etc)
- Age > 18
- American Joint Committee on Cancer (AJCC) stages I-IV
- Curative intent therapy with surgery with or without adjuvant therapy
- Body Image Scale (BIS) score > 5 up to 1 year post-treatment
Exclusion Criteria:
- Inability to speak English
- Known distant metastatic disease
- Inability or unwillingness of subject or legal guardian/representative to give
informed consent
We found this trial at
1
site
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Evan M Graboyes, MD
Phone: 843-792-0719
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
